IRADIMED CORPORATION Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	83.81	73.24	65.56	53.3	41.81
Revenue Growth (YoY)	14.43%	11.71%	23.00%	27.47%	31.84%
Cost of Revenue	19.49	16.89	15.4	12.02	9.76
Gross Profit	64.32	56.35	50.16	41.28	32.05
Selling, General & Admin	35.2	31.59	27.3	23.41	20.36
Research & Development	2.98	2.8	2.82	2.24	1.87
Operating Expenses	38.18	34.39	30.12	25.65	22.23
Operating Income	26.15	21.96	20.04	15.63	9.82
Interest & Investment Income	-	2.19	1.86	0.58	0.03
Currency Exchange Gain (Loss)	-	-0.04	-0.15	-0.04	-0.03
Other Non Operating Income (Expenses)	2.21	0.16	-	-	-
EBT Excluding Unusual Items	28.36	24.28	21.75	16.17	9.82
Gain (Loss) on Sale of Investments	-	-	-	0.01	0.02
Gain (Loss) on Sale of Assets	-	-0	-0.01	-	-
Pretax Income	28.36	24.28	21.74	16.18	9.84
Income Tax Expense	5.88	5.04	4.55	3.35	0.51
Net Income	22.48	19.23	17.19	12.83	9.33
Net Income to Common	22.48	19.23	17.19	12.83	9.33
Net Income Growth	16.88%	11.87%	34.02%	37.56%	581.19%
Shares Outstanding (Basic)	13	13	13	13	12
Shares Outstanding (Diluted)	13	13	13	13	13
Shares Change (YoY)	0.55%	0.48%	0.69%	0.36%	1.21%
EPS (Basic)	1.77	1.52	1.36	1.02	0.76
EPS (Diluted)	1.75	1.50	1.35	1.02	0.74
EPS Growth	16.67%	11.11%	32.35%	37.84%	572.73%
Free Cash Flow	-	17.62	6.02	9.22	10.78
Free Cash Flow Per Share	-	1.38	0.47	0.73	0.86
Dividend Per Share	0.710	0.470	0.150	-	-
Dividend Growth	51.06%	213.33%	-	-	-
Gross Margin	76.75%	76.94%	76.50%	77.45%	76.65%
Operating Margin	31.20%	29.99%	30.56%	29.32%	23.48%
Profit Margin	26.82%	26.26%	26.22%	24.07%	22.30%
Free Cash Flow Margin	-	24.06%	9.19%	17.30%	25.77%
EBITDA	27.19	22.78	20.8	16.3	11.22
EBITDA Margin	32.45%	31.11%	31.73%	30.58%	26.84%
D&A For EBITDA	1.05	0.82	0.77	0.67	1.41
EBIT	26.15	21.96	20.04	15.63	9.82
EBIT Margin	31.20%	29.99%	30.56%	29.32%	23.48%
Effective Tax Rate	20.74%	20.77%	20.91%	20.72%	5.19%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q